Faculty

Institution

Unit

Venue

Harvey R. Herschman

Distinguished Research Professor Molecular and Medical Pharmacology; Distinguished Research Professor Biological Chemistry; Vice Chair for Academic Affairs Molecular and Medical Pharmacology

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Biological Chemistry

Molecular & Medical Pharmacology

Harvey R. Herschman is currently serving as a Biological Chemistry Distinguished Research Professor Molecular and Medical Pharmacology; Distinguished Research Professor Biological Chemistry; Vice Chair for Academic Affairs Molecular and Medical Pharmacology at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harvey R. Herschman

University of California, Los Angeles

Distinguished Research Professor Molecular and Medical Pharmacology; Distinguished Research Professor Biological Chemistry; Vice Chair for Academic Affairs Molecular and Medical Pharmacology

You can click a keyword to filter the displayed items

genetics cell biology pharmacology molecular biology gene expression tumor biology membrane biology cancer research cancer biology oncology protein science mammalian biology medicinal research inflammation cellular physiology enzymes biological chemistry cell signaling brain science cell physiology protein expression enzyme inhibition redox biology vascular biology cellular neurobiology cell regulation cancer genetics biomedical imaging biochemical sciences molecular physiology transcription regulation cellular biology positron emission tomography cancer genomics molecular cell biology gene regulation cancer treatment molecular neurobiology cellular biochemistry epidermal growth factor molecular cancer cancer imaging gene function neural science leukemia protein biosynthesis skin cancer neurochemistry cell culture clinical neuroscience hela cells protein synthesis biochemical genetics host response molecular regulation viral genetics neuroinflammation glucocorticoids tumor targeting living animals metallothionein synthesis biological inorganic chemistry molecular virology viral oncology mast cells growth factors tumor promoters subcellular localization mitogenic response transcriptional regulation noninvasive imaging cultured rat astrocytes glucocorticoid-attenuated response genes heavy metals primary response genes arginine methylation molecular imaging imaging genomics molecular neurodegeneration

Notable Scholarly Works

Notable Federal Grants

Collaborators

Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Arteriosclerosis Thrombosis and Vascular Biology (2023)

Maria VinokurovaMaria Elisa Lopes-PiresNeringa CypaiteFisnik ShalaPaul C. ArmstrongBlerina Ahmetaj-ShalaYoussef ElghazouliRolf NüsingBin LiuYingbi ZhouChuan-ming HaoHarvey R. HerschmanJane A. MitchellNicholas S. Kirkby

tissue fibroblastsangiologycardiologyprostacyclin paradigmregenerative medicinebiomedical engineeringvascular biologyantithrombotic protectionthrombosis

Abstract 14698: Identifying Sources of Prostacyclin Outside the Vascular Wall and Their Contribution to Cardiovascular Protection. Circulation (2022)

Maria Lopes PiresMaria VinokurovaFisnik ShalaBlerina Ahmetaj-ShalaPaul C ArmstrongHarvey R HerschmanJane A MitchellNicholas S Kirkby

inflammationcardiologypharmacologyidentifying sourcesvascular wall

Abstract 14718: Using Renal-Specific Cyclo-Oxygenase-2-Deficient Mice to Understand the Pro-Thrombotic Effects of Non-Steroidal Anti-Inflammatory Drugs. Circulation (2022)

Maria Lopes PiresPlinio FerreiraFisnik ShalaNeringa CypaiteMaria VinokurovaElizabeth WantHarvey HerschmanJane A MitchellNicholas Kirkby

hematologyclinical evidencenon-steroidal anti-inflammatory drugscirculatory physiologyinflammationcardiologymedicinal researchpro-thrombotic effectspharmacologyrespiratory medicinevascular biologynephrologypublic healthanti-inflammatorythrombosishealth sciencescardiovascular disease

Contributors. Elsevier eBooks (2022)

Ron AltermanJeffrey E. ArleKerry BradleySergio CanaveroSteven M. FalowskiChad W. FarleyYakov GologorskyJianwen Wendy GuH. Louis JournéeJohn KastOlga KhazenJoachim K. KraussVignessh KumarMark LentRobert M. LevyAndres M. LozanoCharles MackelGeorge T. MandyburBryan L. McLaughlinDaniel R. MerrillAlon Y. MogilnerGabi MolnarGuillermo A. MonsalveRichard B. NorthYunseo Linda ParkJohn ParkerShrey PatelJulie G. PilitsisFrancisco A. PonceJason E. PopeAdolfo Ramirez-ZamoraLouis J. RasoJoshua M. RosenowJay L. ShilsPeter SingleKonstantin V. SlavinMichael D. StaudtMark M. SteckerHuy Q. Truong

Tissue Fibroblasts Are a Critical Source of Prostacyclin and Anti-Thrombotic Protection. bioRxiv (Cold Spring Harbor Laboratory) (2022)

Jane A. MitchellMaria VinokurovaMaria Elisa Lopes-PiresFisnik ShalaPaul C. ArmstrongBlerina Ahmetaj-ShalaYoussef ElghazouliBin LiuYingbi ZhouChuan-ming HaoHarvey R. HerschmanNicholas S. Kirkby

hematologytissue fibroblastspharmacologyphysiologyanti-thrombotic protectioncritical source

Endothelial Cyclooxygenase-1 Paradoxically Drives Local Vasoconstriction and Atherogenesis Despite Underpinning Prostacyclin Generation. Science Advances (2021)

Jane A. MitchellFisnik ShalaMaria Elisa Lopes PiresRachel Y. LoyAndrew RavendrenJoshua BensonPaula UrquhartAnna NicolaouHarvey R. HerschmanNicholas S. Kirkby

hepatologyhematologyhemostasisinflammationendocrinologyvascular biologyrespiratory medicinephysiologylocal vasoconstrictionhealth sciences

Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated With Poor Prognosis in Lung Cancer Patients. Proceedings of the National Academy of Sciences (2021)

Liu YangXiaowei YanJie ChenQiong ZhanYingqi HuaShili XuZiming LiZhuo WangYu DongDongqing ZuoMin XueYin TangHarvey R. HerschmanShun LuQihui ShiWei Wei

lung cancerclinical evidencecancer biologylung cancer patientspharmacologytumor biologycellular therapycancer researchoncologypoor prognosiscancer carecancer riskhepatologycancer genomicsmedicinal researchdermatologycancer cellscancer managementthoracic oncologyhealth sciences

Author Correction: Chronic Il-1β-Induced Inflammation Regulates Epithelial-To-Mesenchymal Transition Memory Phenotypes via Epigenetic Modifications in Non-Small Cell Lung Cancer. Scientific Reports (2020)

Rui LiStephanie L. OngLinh M. TranZhe JingBin LiuStacy J. ParkZi Ling HuangTonya C. WalserEileen L. HeinrichGina LeeRamin Salehi-RadWilliam P. CrossonPaul C. PaganoManash K. PaulShili XuHarvey HerschmanKostyantyn KrysanSteven Dubinett

lung cancerchronic inflammationleukemiapharmacologyepigenetic modificationsscientific datatumor biologycellular therapyoncologycancer researchcell regulationauthor correctioncancer genomicsmolecular canceradaptive immune systemimmunologyhealth sciencesmedicinal researchinflammationcancer genetics

Comparison of the Efficacy and Sensitivity of Alternative Pet Reporter Gene/Pet Reporter Probe Systems That Minimize Biological Variables. Methods in molecular biology (2020)

Shili XuHarvey R. Herschman

molecular biologypharmacologygene expressionbiological variables

Exosomal 2′,3′-Cnp From Mesenchymal Stem Cells Promotes Hippocampus Ca1 Neurogenesis/Neuritogenesis and Contributes to Rescue of Cognition/Learning Deficiencies of Damaged Brain. Stem Cells Translational Medicine (2020)

Shih-Yin ChenMeng-chieh LinJia-Shiuan TsaiPei-Lin HeWen-Ting LuoIng-Ming ChiuHarvey R. HerschmanHua-Jung Li

stem cell researchgeneticscognitive impairmentdevelopmental neurobiologyneuroregenerationstem cellsneuroprotectionbrain sciencebrain organizationneurosciencecentral nervous systemlearning disabilitiesneurologybrain injurybrain function

1
2
3
4
5
34
10 / page

Harvey R. Herschman

Distinguished Research Professor Molecular and Medical Pharmacology; Distinguished Research Professor Biological Chemistry; Vice Chair for Academic Affairs Molecular and Medical Pharmacology

University of California, Los Angeles

Affiliations

David Geffen School of Medicine

Biological Chemistry

Molecular & Medical Pharmacology

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harvey R. Herschman

University of California, Los Angeles

Distinguished Research Professor Molecular and Medical Pharmacology; Distinguished Research Professor Biological Chemistry; Vice Chair for Academic Affairs Molecular and Medical Pharmacology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. Arteriosclerosis Thrombosis and Vascular Biology (2023)

tissue fibroblastsangiologycardiologyprostacyclin paradigmregenerative medicinebiomedical engineeringvascular biologyantithrombotic protectionthrombosis

Abstract 14698: Identifying Sources of Prostacyclin Outside the Vascular Wall and Their Contribution to Cardiovascular Protection. Circulation (2022)

Maria Lopes PiresMaria VinokurovaFisnik ShalaBlerina Ahmetaj-ShalaPaul C ArmstrongHarvey R HerschmanJane A MitchellNicholas S Kirkby

inflammationcardiologypharmacologyidentifying sourcesvascular wall

Abstract 14718: Using Renal-Specific Cyclo-Oxygenase-2-Deficient Mice to Understand the Pro-Thrombotic Effects of Non-Steroidal Anti-Inflammatory Drugs. Circulation (2022)

Maria Lopes PiresPlinio FerreiraFisnik ShalaNeringa CypaiteMaria VinokurovaElizabeth WantHarvey HerschmanJane A MitchellNicholas Kirkby

Contributors. Elsevier eBooks (2022)

Tissue Fibroblasts Are a Critical Source of Prostacyclin and Anti-Thrombotic Protection. bioRxiv (Cold Spring Harbor Laboratory) (2022)

Jane A. MitchellMaria VinokurovaMaria Elisa Lopes-PiresFisnik ShalaPaul C. ArmstrongBlerina Ahmetaj-ShalaYoussef ElghazouliBin LiuYingbi ZhouChuan-ming HaoHarvey R. HerschmanNicholas S. Kirkby

hematologytissue fibroblastspharmacologyphysiologyanti-thrombotic protectioncritical source

Endothelial Cyclooxygenase-1 Paradoxically Drives Local Vasoconstriction and Atherogenesis Despite Underpinning Prostacyclin Generation. Science Advances (2021)

Jane A. MitchellFisnik ShalaMaria Elisa Lopes PiresRachel Y. LoyAndrew RavendrenJoshua BensonPaula UrquhartAnna NicolaouHarvey R. HerschmanNicholas S. Kirkby

hepatologyhematologyhemostasisinflammationendocrinologyvascular biologyrespiratory medicinephysiologylocal vasoconstrictionhealth sciences

Hexokinase 2 Discerns a Novel Circulating Tumor Cell Population Associated With Poor Prognosis in Lung Cancer Patients. Proceedings of the National Academy of Sciences (2021)

Liu YangXiaowei YanJie ChenQiong ZhanYingqi HuaShili XuZiming LiZhuo WangYu DongDongqing ZuoMin XueYin TangHarvey R. HerschmanShun LuQihui ShiWei Wei

Comparison of the Efficacy and Sensitivity of Alternative Pet Reporter Gene/Pet Reporter Probe Systems That Minimize Biological Variables. Methods in molecular biology (2020)

Shili XuHarvey R. Herschman

molecular biologypharmacologygene expressionbiological variables

Shih-Yin ChenMeng-chieh LinJia-Shiuan TsaiPei-Lin HeWen-Ting LuoIng-Ming ChiuHarvey R. HerschmanHua-Jung Li

1
2
3
4
5
34
10 / page

Similar Faculty Members

Gary Johnson

Institution

University of North Carolina at Chapel Hill

mapk kinase

apoptosis

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Kamel Khalili

Institution

Temple University

neuroscience

neurodegenerative disease

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Matteo Pellegrini

Institution

University of California, Los Angeles

gene expression

epigenetics

Paul Insel

Institution

University of California, San Diego

gastrointestinal peptide hormone

gpcr expression

Similar Faculty Members

Gary Johnson

Institution

University of North Carolina at Chapel Hill

mapk kinase

apoptosis

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Kamel Khalili

Institution

Temple University

neuroscience

neurodegenerative disease

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Matteo Pellegrini

Institution

University of California, Los Angeles

gene expression

epigenetics

Paul Insel

Institution

University of California, San Diego

gastrointestinal peptide hormone

gpcr expression